← Back to contracts

DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award

US · MD Dept › of the Army -- USAMRAA (U › S › Army Medical Research Acquisition Activity) grant open #HT942526TBDRPTDRA
Response due Oct 22, 2026 · 00:00 UTC

Summary

The Department of the Army's U.S. Army Medical Research Acquisition Activity (USAMRAA) is funding research focused on therapeutics and/or diagnostics for tick-borne diseases. This is a federal grant/research award opportunity posted on Grants.gov. The opportunity targets investigator-initiated research aimed at advancing treatment or detection capabilities for tick-borne illnesses. Full scope details are not provided in the synopsis.

How they evaluate

Submission: Grants.gov federal grants portal (grants.gov)

Risks & flags

  • Synopsis contains almost no substantive scope details — full program requirements, eligibility, and evaluation criteria are not disclosed in the posted document
  • Opportunity number (HT942526TBDRPTDRA) suggests a pre-structured program announcement; award criteria and funding levels are unknown

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Tick-Borne Disease Therapeutic/Diagnos…
Due Oct 22
Onboard